Identification of xanthurenic acid 8-O-β-D-glucoside and xanthurenic acid 8-O-sulfate as human natriuretic hormones

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 45, 2007, Pages 17873-17878

  Cain, Christopher D ^a   Schroeder, Frank C ^b,c   Shankel, Stewart W ^a   Mitchnick, Mark ^a   Schmertzler, Michael ^a   Bricker, Neal S ^a  

^a Naturon Pharmaceutical Corporation   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c United States Department of Agriculture Agricultural Research Service and Boyce Thompson Institute for Plant Research   (United States)

Author keywords

Diuresis; Kidney; NMR spectroscopy; Nonpeptidic; Sodium homeostasis

Indexed keywords

NATRIURETIC FACTOR; TRYPTOPHAN; UNCLASSIFIED DRUG; XANTHURENIC ACID; XANTHURENIC ACID 8 GLUCOSIDE; XANTHURENIC ACID 8 O SULFATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURETIC ACTIVITY; FEMALE; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SYNTHESIS; HUMAN; MASS SPECTROMETRY; NATRIURESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT; SPRAGUE DAWLEY RAT; URINE;

GLUCOSIDES; HUMANS; KIDNEY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NATRIURETIC AGENTS; SULFATES; SULFURIC ACID ESTERS; WATER-ELECTROLYTE BALANCE; XANTHURENATES;

RATTUS;

EID: 36749070968     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0705553104     Document Type: Article

References (28)

1. de Wardener HE, Clarkson EM (1985) Physiol Rev 65:658-759.
2. de Wardener HE, Mills IH, Clapham WF, Hayter CJ (1961) Clin Sci 21:249-258.
3. Mills IH, de Wardener HE, Hayter CJ, Clapham WF (1961) Clin Sci 21:259-264.
4. Bourgoignie J, Hwang KH, Ipakchi E, Bricker NS (1974) J Clin Invest 53:1559-1567.
5. Bricker NS, Zea L, Shapiro M, Sanclemente E, Shankel S (1993) Kidney Int 44:937-947.
6. Clarkson EM, Young DR Raw SM, de Wardener HE (1980) in Hormone Regulation of Sodium Excretion, eds Lichardus B Schrier RW, Ponec J (Elsevier/North-Holland Amsterdam) pp 333-340.
7. Viskoper RJ, Czaczkes JW, Schwartz N, Ullmann TD (1971) Nephron 8:540-548.
8. Clarkson EM, Raw SM, de Wardener HE (1976) Kidney Int 10:381-394.
9. Bricker NS, Klahr S, Purkerson M, Schultze RG, Avioli LV, Birge SJ (1968) Nature (London) 219:1058-1059.
10. Gonick HC, Saldanha LF (1975) J Clin Invest 56:247-255.
11. Ferrandi M, Manuta P (2000) Curr Opin Nephrol Hypertens 9:165-171.
12. Klingmuler D, Weiler E, Kramer HJ (1982) Klin Wochenschr 60:1249-1253.
13. Bourgoignie J, Klahr S, Bricker NS (1971) J Clin Invest 50:303-311.
14. Dzurik R, Lichardus B, Spustova J, Ponec J, Gerykova A, Bakos PA (1982) Physio Bohemosdov 31:573-576.
15. Kaplan MA, Bourgoignie JJ, Rosecan J, Bricker NS (1974) J Clin Invest 53:1568-1577.
16. Fine LG, Bourgoignie JJ, Hwang KH, Bricker NS (1976) J Clin Invest 58:590-597.
17. Buckalew VM, Jr, Martinez FJ, Green WE (1970) J Clin Invest 49:926-935.
18. Favre H, Hwang KH, Schmidt RW, Bricker NS (1975) J Clin Invest 56:1302-1311.
19. Ussing HH, Zerahn K (1951) Acta Physiol Scand 23:110-127.
20. Fine LG, Bourgoigne JJ, Weber H, Bricker NS (1976) Kidney Int 10:364-372.
21. Schröder FC, Farmer J, Attygalle AB, Smedley SR, Eisner T, Meinwald J (1998) Science 281:428-431.
22. Taggi AE, Meinwald J, Schroeder FC (2004) J Am Chem Soc/I 126:10364-10369.
23. Schroeder FC, Weibel DB, Meinwald J (2004) Org Lett 6:3019-3022.
24. Stone TW, Darlington LG (2002) Nat Rev Drug Discov 1:609-620.
25. Bahn A, Ljubojevic M, Lorenz H, Schultz C, Ghebremedhin E, Ugele B, Sabolic I, Burckhardt G, Hagos Y (2005) Am J Physiol 289:C1075-C1084.
26. Anne Shane M, Nofziger C, Blazer-Yost B (2006) Gen Compar Endocrin 147:85-92.
27. Loffing J, Kaissling B (2003) Am J Physiol 284:F628-F643.
28. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA (2004) Physiol Genomics 19:233-246.